STAT Brand Studio

About STAT Brand Studio

Catalysts in Science explores the ideas and leaders shaping the future of health care, medicine, and the life sciences. Scientists, executives, clinicians, and other experts discuss the breakthroughs, research, and decisions moving their fields forward. Episodes are produced by STAT Brand Studio as sponsored content.

Publisher

STAT Brand Studio

Category

business · health & fitness · science

Language

en

Explicit

No

First episode

7 Aug 2024

Latest episode

23 Jul 2026

Latest episodes

18 episodes in the feed.

1. 

   23 Jul 2026

   Fifteen years later, Undetectable = Untransmittable continues to shape HIV care

   Fifteen years after the HIV Prevention Trials Network (HPTN) 052 study changed the understanding of HIV transmission, its influence continues to extend far beyond the clinic. In this conversation, Jared Baeten of Gilead reflects on how the landmark study gave rise to Undetectable = Untransmittable, where according to this research, taking HIV treatment as prescribed and getting to and staying undetectable, prevents sexual transmission of HIV, helping reduce stigma while reshaping HIV care. He also discusses why the next phase of innovation will depend on listening to patients, expanding access to care, and developing new treatment and prevention options that meet people where they are. Listen: https://www.statnews.com/sponsor/2026/07/23/fifteen-years-later-uu-continues-to-shape-hiv-care/

2. 

   25 Jun 2026

   New approaches for cancer’s toughest challenges

   Advances in oncology are creating new opportunities to deliver more personalized care for patients. In this sponsored conversation, Dr. Mika Kakefuda Derynck, Senior Vice President and Therapeutic Area Head of Oncology at Gilead Sciences, and Dr. Gallia Levy, Senior Vice President and Global Head of Development at Kite, discuss the future of cancer treatment, including antibody-drug conjugates (ADCs), CAR-T cell therapies, patient-centered clinical trial design, and efforts to improve access to innovative treatments. Moderated by Terzel Vasquez. Read more: https://www.statnews.com/sponsor/2026/06/25/new-approaches-for-cancers-toughest-challenges/

3. 

   16 Apr 2026

   How unmet patient needs are shaping the next phase of cancer research

   Oncology leaders Jackson Egen of Gilead Sciences and Priti Hegde of Kite, a Gilead company, discuss how unmet patient needs are shaping the next phase of cancer research. They explore how Gilead and Kite are approaching oncology across multiple fronts, drawing on advances in blood cancers and applying those lessons to solid tumors such as glioblastoma, alongside continued progress in cell therapy and other biology‑driven therapeutic approaches. Moderated by Jesse McQuarters. Read more: https://www.statnews.com/sponsor/2026/04/16/how-unmet-patient-needs-are-shaping-the-next-phase-of-cancer-research/ Image credit: Radhika Patnala/Endosymbiont GmBH

4. 

   20 Mar 2026

   Could U.S. policy clinch China’s grip on biotech?

   Drug pricing reforms were meant to protect patients — but they may also be reshaping where innovation happens. In this interview, John Stanford of Incubate explains how MFN price controls and regulatory uncertainty ripple through the biotech ecosystem, squeezing small innovators and pushing investment abroad. Moderated by Terzel Vasquez, Producer, STAT Brand Studio. Read more: https://www.statnews.com/sponsor/2026/03/04/could-u-s-policy-clinch-chinas-grip-on-biotech/

5. 

   24 Feb 2026

   Astellas CEO talks transformative medicines driving growth

   At the 2026 JPM Conference in San Francisco, Astellas President and CEO Naoki Okamura spoke with STAT Brand Studio Editor Jesse McQuarters about the company’s strategy and long-term vision as it enters an important phase in the company’s evolution. Astellas is taking a patient-centered approach and investing in four key areas within R&D — targeted protein degradation, immuno-oncology, blindness and regeneration, and genetic regulation — as it prepares for the loss of exclusivity of its leading prostate cancer therapy. Read more here: https://www.statnews.com/sponsor/2026/02/23/astellas-ceo-talks-transformative-medicines-driving-growth/

6. 

   20 Feb 2026

   Bridging gaps in asthma care

   People living with asthma understand that their environment affects their health, but they’re often left without the tools, guidance, or support to fully act on that knowledge. In this virtual event, Chiesi unveils findings from its recent Asthma Community Survey, which looks at this fundamental gap and potential solutions. In particular, this conversation explores how embedding Environmental Health Literacy (EHL) into clinical, community, and digital systems can help individuals navigate air quality improvements with greater confidence, and panelists lay out a roadmap for building more responsive, patient-centered asthma care. • Anju T. Peters, M.D. M.SCI, Professor of Medicine, Director of Clinical Research, Division of Allergy and Immunology, Director, Center for Clinical Research, Northwestern University Clinical and Translational, Sciences Institute (NUCATS), Medical Director, Northwestern Medicine Clinical Research Unit, Northwestern University Feinberg School of Medicine • Cindy Trubisky, M.Ed., AE-C, Senior Director, Nationwide Health Promotions, Asthma Programs, American Lung Association • Jesse McQuarters, Editor, STAT Brand Studio Read more: https://www.statnews.com/sponsor/2025/12/01/do-enough-allergists-and-pcps-know-about-environmental-health-literacy/

7. 

   4 Dec 2025

   The Nucleus x SBS: How proteomics and multi-omics are deepening our understanding of human health

   Dr. John Overton discusses with Jesse McQuarters how proteomics and multi-omics integration provides deeper insights into disease development, improving prediction and prevention in this interview.

8. 

   9 Oct 2025

   “Taking possibility back” across oncology’s toughest frontiers

   Chief Medical Officer Dr. Dietmar Berger at Gilead Sciences discusses tackling urgent needs in triple negative breast cancer and pioneering the next generation of CAR-T therapies to reshape oncology possibilities in this interview.

9. 

   18 Sept 2025

   Can provider education and smarter policy close the biosimilars gap?

   Linda Choi MacDonald explores the obstacles hindering biosimilar advancement and suggests that policy changes, incentives, and provider education can bridge the gap in this interview.

10. 

    25 Aug 2025

    From research to advocacy: A new fellowship honors Stephen Harrison’s vision in MASH research

    Wayne Eskridge and Dr. Maru Rinella discuss how a new fellowship honors Dr. Stephen Harrison's vision for MASH research by empowering patient advocates, interviewed by Jesse McQuarters.

11. 

    12 Jun 2025

    Supporting science from bench to bioproduction

    Jesse McQuarters interviews Jerry Keybl about Avantor's partnerships and solutions that help biotech and biopharma companies overcome scientific and operational challenges from research to commercialization.

12. 

    22 May 2025

    Building the future of life sciences in NYC

    New York City is investing over $1 billion to become a global leader in the life sciences — and at the heart of that mission is a commitment to infrastructure, innovation, and equity. In this episode, STAT Brand Studio editor Jesse McQuarters speaks with Viq Pervaaz, senior vice president at NYCEDC, about how the LifeSci NYC initiative is transforming the city’s health and science ecosystem. From modern lab spaces and AI-driven research to workforce programs reaching thousands of students, the conversation explores how New York is merging economic and social impact to build the future of medicine.

13. 

    20 Mar 2025

    Puerto Rico’s competitive edge: Workforce, incentives, and cutting-edge infrastructure

    Puerto Rico is emerging as a key biopharma hub, offering advanced manufacturing capabilities, a highly skilled workforce, and significant cost advantages. In this conversation, OcyonBio CEO Robert Salcedo discusses how his company is leveraging AI-driven manufacturing, modular wet labs, and strategic infrastructure to support biotech and gene therapy companies.

14. 

    2 Jan 2025

    Fighting colorectal cancer disparities with real-world data

    Colorectal cancer remains the second leading cause of cancer deaths, with disparities in screening and care access posing major challenges. At the 2024 STAT Summit, Dr. Angie Nicholas and Dr. Fola May discussed how real-world data and collaboration among diverse stakeholders is driving efforts to close these gaps and achieve ambitious goals like 80% screening rates by 2030.

15. 

    4 Dec 2024

    Three-year degree expands access to medical education and fast-tracks specialty study

    NYU Grossman School of Medicine is transforming medical education with an innovative three-year medical degree and tuition-free enrollment. Senior Associate Dean Joan Cangiarella, M.D., highlights the school's commitment to curriculum reform and personalized learning pathways designed to equip students for their preferred specialties while eliminating financial barriers to entry.

16. 

    6 Nov 2024

    Top-ranked health system launches wide-ranging molecular oncology program

    Molecular testing tools, including tumor sequencing and increasingly sensitive diagnostics, are leveling up oncology by enabling precise, personalized cancer treatment. Clinicians can now detect circulating tumor DNA, assess patients' cancer risk, monitor for resistance mutations, and adjust treatments in real time. Dr. Alec Kimmelman, director of the Perlmutter Cancer Center, discusses how NYU Langone’s integrated infrastructure enhances data-driven clinical decisions and contributes to groundbreaking cancer research.

17. 

    9 Oct 2024

    Approaching patient care with understanding, respect, and humility

    As CEO of NYU Langone Health and dean of the Grossman School of Medicine, Dr. Robert Grossman leads a health system that excels in patient-oriented metrics, with a strategic eye toward the future. In this STAT Brand Studio podcast, he details the organization's landmark accomplishments over the last 17 years and singular culture rooted in respect for employees and patients.

18. 

    7 Aug 2024

    STAT Summit 2024

    Changing medicine? It’s hard. Here’s how to do it It doesn’t take a rocket scientist to see that getting new health technologies to market is incredibly hard, with companies in biotech and health tech falling apart as the funding environment worsens. By gathering real operators from the trenches who have not previously spoken out, not just talking heads, we’ll cover some of the biggest challenges faced by those who want to move advances out of the lab and into the world.We’ll discuss everything from drug development and technology invention to dealing with regulators, courting investors, and pricing and selling products.

Who has been a guest on STAT Brand Studio

Names identified in recent episode analyses. Showing up to five guests.

• Dr John Overton
• Dr Dietmar Berger
• Linda Choi MacDonald
• Jerry Keybl

Reach and audience

Public platform figures. Ratings count people who left a rating, not total listeners.

Spotify

5.0 / 5

3 ratings

Podcast Authority Score: 12 / 100

A composite of feed quality, social presence, YouTube performance and engagement. Read the methodology.

Quality

11

Social presence

0

YouTube

0

Engagement

32